- Filed
- Jul 25, 2022 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2020 · Jul 12, 2022 | 165.19M sh |
| Cash And Equivalents | Q3 2020 · Sep 30, 2020 | $27.39K |
| Cash And Equivalents | Q3 2020 · Dec 31, 2019 | $9.33K |
| Current Liabilities | Q3 2020 · Sep 30, 2020 | $313.22K |
| Current Liabilities | Q3 2020 · Dec 31, 2019 | $221.64K |
| Total Liabilities | Q3 2020 · Sep 30, 2020 | $877.53K |
| Total Liabilities | Q3 2020 · Dec 31, 2019 | $747.46K |
| Current Assets | Q3 2020 · Sep 30, 2020 | $151.67K |
| Current Assets | Q3 2020 · Dec 31, 2019 | $70.76K |
| Total Assets | Q3 2020 · Sep 30, 2020 | $151.67K |
| Total Assets | Q3 2020 · Dec 31, 2019 | $70.76K |
| Shares Diluted | Q3 2020 · Sep 30, 2019 | 165.19M sh |
| Shares Diluted | Q3 2020 · Sep 30, 2019 | 165.19M sh |
| Operating Cash Flow restated | Q3 2020 · Sep 30, 2019 | $101.98K |
| Stockholders Equity | Q3 2020 · Sep 30, 2019 | −$595.07K |
| Stockholders Equity | Q3 2020 · Jun 30, 2019 | −$620.33K |
| Stockholders Equity | Q3 2020 · Mar 31, 2019 | −$713.85K |
| Stockholders Equity | Q3 2020 · Dec 31, 2018 | −$670.89K |
| Eps Diluted | Q3 2020 · Sep 30, 2019 | $0.00 |
| Eps Diluted | Q3 2020 · Sep 30, 2019 | $0.00 |
| Eps Basic | Q3 2020 · Sep 30, 2019 | $0.00 |
| Eps Basic | Q3 2020 · Sep 30, 2019 | $0.00 |
| Sga Expense restated | Q3 2020 · Sep 30, 2019 | $149.95K |
| Sga Expense restated | Q3 2020 · Sep 30, 2019 | $441.42K |
| Net Income | Q3 2020 · Sep 30, 2019 | $25.26K |
| Net Income | Q3 2020 · Sep 30, 2019 | $75.83K |
| Net Income | Q3 2020 · Jun 30, 2019 | $93.52K |
| Net Income | Q3 2020 · Mar 31, 2019 | −$42.96K |
| Operating Income restated | Q3 2020 · Sep 30, 2019 | $24.17K |
| Operating Income restated | Q3 2020 · Sep 30, 2019 | −$1.44K |
| Revenue | Q3 2020 · Sep 30, 2019 | $174.12K |
| Revenue | Q3 2020 · Sep 30, 2019 | $439.97K |